This article is more than 5 years old. Information may no longer be current.
Vitiligo treatment recommendations top dermatology reads for week
The Vitiligo Working Group’s recommendations regarding the use of narrowband ultraviolet B light for treating vitiligo was among the most-read articles of the past week on Healio.com/Dermatology.
Other widely read articles included study findings that there was an increased risk for inflammatory bowel disease in patients with rosacea and that the effects of Juvéderm Volbella XC treatment for lip and perioral enhancement lasted through 1 year:
Group makes recommendations for phototherapy treatment of vitiligo
The Vitiligo Working Group has made a set of recommendations regarding the use of narrowband ultraviolet B light for the treatment of vitiligo.
“Treatment of vitiligo with narrowband ultraviolet B light is an important component of the current standard of care,” the authors wrote. “However, there are no consistent guidelines regarding the dosing and administration of [narrow band ultraviolet B light] in vitiligo, reflected by varied treatment practices around the world.” Read more
Rosacea may be tied to increased risk for inflammatory bowel disease
There was an increased risk for inflammatory bowel disease in patients with rosacea, according to study results published in the Journal of the American Academy of Dermatology.
Researchers in Taiwan used the Taiwanese National Health Insurance Research Database to identify 89,356 patients with rosacea and 178,712 matched patients without rosacea (reference cohort) between 1997 and 2013 for analysis. Read more
Juvéderm Volbella XC effective for lip, perioral enhancements up to 1 year
Juvéderm Volbella XC treatment for lip and perioral enhancement was safe and effective, with the effects of treatment lasting through 1 year, according to study results published in Dermatologic Surgery.
Roy G. Geronemus, MD, of the Laser & Skin Surgery Center of New York, and colleagues conducted a randomized study of 225 adults (median age, 54 years; 96.9% women) with minimal, mild or moderate lip fullness, using a validated 5-point Allergan Lip Fullness Scale. Read more
Low-level light therapy improved periocular wrinkles
Low-level light therapy significantly and safely improved facial skin wrinkles, according to study results published in Dermatologic Surgery.
Researchers in Korea conducted a prospective double-blind study of 52 women aged between 30 and 65 years with more than grade 3 lateral periocular wrinkles. Read more
FDA approves Siliq for treating psoriasis
The FDA announced that it has approved Siliq as treatment for moderate-to-severe plaque psoriasis.
Siliq (brodalumab, Valeant Pharmaceuticals) is administered by injection and is intended for patients who are candidates for systemic therapy or phototherapy and have failed to respond or have stopped responding to other systemic therapies, according to a press release. Read more